Skip to Content


As a leader in our SEC practice, I primarily assist public companies with SEC filings, including initial public offerings (IPOs), secondary public offerings (SPOs), reverse mergers, and complex financing transactions. In addition, in my work with biotechnology and life sciences organizations, I specialize in advising executives, so they can stay on the cutting edge of the bioscience industry regulations, trends, and financial best practices. I also have expertise in debt and equity financing transactions.
View More of Rebecca's Experience
I’m a Colorado native with no interest in living anywhere else. My family likes being active and enjoys all the state has to offer — from the mountains, beautiful seasons, skiing, and just being together.

You might also like…

Energy companies: Q3 2021 accounting and reporting update
Diane Kirk
Article October 15, 2021 8 min read
Audit committee quarterly update
Diane Kirk
Article October 12, 2021 10 min read
Accounting and regulatory update for public and private companies
Diane Kirk
Article October 11, 2021 20 min read
GASB accounting standard update: Fall 2021
Michelle Watterworth
Article September 20, 2021 1 min read